Skip to main content

Advertisement

SpringerLink
Log in

Outcomes of Partial Mastectomy in Male Breast Cancer Patients: Analysis of SEER, 1983–2009

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Although mastectomy is considered the gold standard for male breast cancer (MBC), the utilization of lumpectomy and its impact on outcomes in MBC patients has not been previously studied.

Methods

The Surveillance, Epidemiology and End Results (SEER) database was used to identify all MBC patients who underwent either mastectomy or less than mastectomy (i.e., lumpectomy) between 1983 and 2009.

Results

A total of 4707 (86.8 %) men underwent mastectomy and 718 (13.2 %) underwent lumpectomy. A greater proportion of patients underwent lumpectomy later in the study period (1983 to 1986, 10.6 %, vs. 2007 to 2009, 15.1 %). A greater percentage of lumpectomy patients were 80 years or older (21.3 % vs. 16.3 %), had stage IV disease (7.3 % vs. 3.1 %), and received no lymph node sampling (34.3 % vs. 6.9 %). Only 35.4 % of patients underwent adjuvant radiotherapy after lumpectomy. Ten-year breast cancer-specific survival and overall survival were 82.8 % and 46.9 %, respectively, in lumpectomy patients vs. 77.3 % and 46.4 %, respectively, in mastectomy patients. On Cox proportional hazards regression, lumpectomy was not independently associated with worse breast cancer-specific survival (odds ratio 1.09, 95 % confidence interval 0.87–1.37) or overall survival (odds ratio 1.12, 95 % confidence interval 0.98–1.27) after controlling for age, race, stage, and grade, as well as whether radiotherapy was received.

Conclusions

Lumpectomy is performed in a small but growing proportion of MBC patients. These patients are not only older and more likely to have advanced disease at the time of diagnosis, but they also are less likely to receive standard of care therapy, such as lymph node sampling and adjuvant radiotherapy. Despite these observations, breast cancer-specific survival is unaffected by the type of surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367(9510):595–604.

    Article  PubMed  Google Scholar 

  2. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–7.

    Article  PubMed  Google Scholar 

  3. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.

    Article  PubMed  Google Scholar 

  4. Albo D, Ames FC, Hunt KK, et al. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat. 2003;77:9–14.

    Article  PubMed  CAS  Google Scholar 

  5. Port ER, Fey JV, Cody HS 3rd, Borgen PI. Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer. 2001;91:319–23.

    Article  PubMed  CAS  Google Scholar 

  6. Boughey JC, Bedrosian I, Meric-Bernstam F, et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006;203:475–80.

    Article  PubMed  Google Scholar 

  7. Cimmino VM, Degnim AC, Sabel MS, et al. Efficacy of sentinel lymph node biopsy in male breast cancer. J Surg Oncol. 2004;86:74–7.

    Article  PubMed  Google Scholar 

  8. Lanitis S, Filippakis G, Al Mufti R, Hadjiminas DJ. Breast conserving surgery with preservation of the nipple–areola complex as a feasible and safe approach in male breast cancer: a case report. J Med Case ReP. 2008;2:126.

    Google Scholar 

  9. Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast. 2007;16:653–6.

    Article  PubMed  Google Scholar 

  10. Bratman SV, Kapp DS, Horst KC. Evolving trends in the initial locoregional management of male breast cancer. Breast. 2012;21:296–302.

    Article  PubMed  Google Scholar 

  11. Cutuli B, Dilhuydy JM, De Lafontan B, et al. Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer. 1997;33:35–8.

    Article  PubMed  CAS  Google Scholar 

  12. Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years, 1955–1996. Cancer. 1999;85:629–39.

    Article  PubMed  CAS  Google Scholar 

  13. Gough DB, Donohue JH, Evans MM, et al. A 50-year experience of male breast cancer: is outcome changing? Surg Oncol. 1993;2:325–33.

    Article  PubMed  CAS  Google Scholar 

  14. Niikura N, Kimura M, Hirabayashi K, et al. Breast conserving surgery for male noninvasive intracystic papillary carcinoma: a case report. Tokai J ExP Clin Med. 2010;35:13–6.

    PubMed  Google Scholar 

  15. Wang J, Kollias J, Marsh C, Maddern G. Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand? Breast. 2009;18:378–81.

    Article  PubMed  Google Scholar 

  16. Nguyen T, Cowher M. Demand for breast-conserving surgery among male breast cancer patients. Presented at: 13th Annual Meeting of American Society of Breast Surgeons, Phoenix, AZ, 2012.

  17. Schain WS, D’Angelo TM, Dunn ME, Lichter AS, Pierce LJ. Mastectomy versus conservative surgery and radiation therapy. Psychosocial consequences. Cancer. 1994;73:1221–8.

    CAS  Google Scholar 

  18. Parker PA, Youssef A, Walker S, et al. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol. 2007;14:3078–89.

    Article  PubMed  Google Scholar 

  19. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Breast cancer. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed November 1, 2012.

  20. Olivotto A, Coldman AJ, Hislop TG, et al. Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol. 1997;15:216–22.

    PubMed  CAS  Google Scholar 

  21. Mor V, Laliberte LL, Petrisek AC, et al. Impact of breast cancer treatment guidelines on surgeon practice patterns: results of a hospital-based intervention. Surgery. 2000;128:847–61.

    Article  PubMed  CAS  Google Scholar 

  22. Hershman DL, Buono D, McBride RB, et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst. 2008;100:199–206.

    Article  PubMed  Google Scholar 

  23. Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB. Surgeon characteristics and variations in treatment for early-stage breast cancer. Arch Surg. 2007;142:17–22.

    Article  PubMed  Google Scholar 

  24. Yood MU, Owusu C, Buist DSM, et al. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg. 2008;206:66–75.

    Article  PubMed  Google Scholar 

  25. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  26. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  PubMed  Google Scholar 

  27. Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview. Urol Oncol. 2012;30:126–32.

    Article  PubMed  Google Scholar 

  28. Korde LA, Zujewski JA, Kamin L, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010;28:2114–22.

    Article  PubMed  Google Scholar 

  29. ClinicalTrials.gov. Clinical trials of male breast cancer. Available at: http://clinicaltrials.gov/ct2/results?term=male+breast+cancer&Search=Search. Accessed November 12, 2012.

Download references

Disclosure

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgery, Stanford University, Stanford, CA, USA

    Jordan M. Cloyd MD, Tina Hernandez-Boussard PhD, MPH & Irene L. Wapnir MD

Authors
  1. Jordan M. Cloyd MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tina Hernandez-Boussard PhD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irene L. Wapnir MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jordan M. Cloyd MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cloyd, J.M., Hernandez-Boussard, T. & Wapnir, I.L. Outcomes of Partial Mastectomy in Male Breast Cancer Patients: Analysis of SEER, 1983–2009. Ann Surg Oncol 20, 1545–1550 (2013). https://doi.org/10.1245/s10434-013-2918-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-2918-5

Keywords

Search

Navigation